Bone formation in interleukin-4 and interleukin-13 depleted mice

Acta Orthopaedica

Volumn 79, Issue 3, 2008, Pages 410-420

  Silfverswärd, Carl Johan ^a   Sisask, Gregor ^a   Larsson, Sune ^a   Ohlsson, Claes ^b   Frost, Anders ^a   Ljunggren, Östen ^a   Nilsson, Olle ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BONE DEMINERALIZATION; BONE MATRIX; CALLUS; CONTROLLED STUDY; FEMALE; FRACTURE; FRACTURE HEALING; IMMUNOHISTOCHEMISTRY; IMPLANT; MALE; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN DEPLETION; RADIODIAGNOSIS; WILD TYPE; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BONE DEVELOPMENT; BONE REMODELING; COMPARATIVE STUDY; HETEROTOPIC OSSIFICATION; HISTOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BONE DEMINERALIZATION TECHNIQUE; BONE MATRIX; BONE REMODELING; BONY CALLUS; FEMALE; FRACTURE HEALING; FRACTURES, BONE; INTERLEUKIN-13; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS;

EID: 47249149752     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670710015337     Document Type: Article

References (35)

1. Barnes G L, Kostenuik P J, Gerstenfeld L C, Einhorn T A. Growth factor regulation of fracture repair. J Bone Miner Res 1999; 14 (11): 1805-15.
2. Bhandari M, Shaughnessy S. A minimally invasive percutaneous technique of intramedullary nail insertion in an animal model of fracture healing. Arch Orthop Trauma Surg 2001; 121 (10): 591-3.
3. Bjurholm A, Kreicbergs A, Schultzberg M, Lerner U H. Parathyroid hormone and noradrenaline-induced enhancement of cyclic AMP in a cloned osteogenic sarcoma cell line (UMR 106) is inhibited by neuropeptide Y. Acta Physiol Scand 1988; 134 (3): 451-2.
4. Bjurholm A, Kreicbergs A, Schultzberg M, Lerner U H. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res 1992; 7 (9): 1011-9.
5. Bolander M E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992; 200 (2): 165-70.
6. Canalis E, McCarthy T L, Centrella M. The role of growth factors in skeletal remodeling. Endocrinol Metab Clin North Am 1989; 18 (4): 903-18.
7. Canalis E, McCarthy T L, Centrella M. Growth factors and cytokines in bone cell metabolism. Annu Rev Med 1991; 42: 17-24.
8. Croteau S, Rauch F, Silvestri A, Hamdy R C. Bone morphogenetic proteins in orthopedics: from basic science to clinical practice. Orthopedics 1999; 22 (7): 686-95; quiz 696-7.
9. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289 (5484): 1501-4.
10. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267 (16): 10931-4.
11. Frost A, Jonsson K B, Brandstrom H, Ljunghall S, Nilsson O, Ljunggren O. Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha. Bone 2001; 28 (3): 268-74.
12. Hiltunen A, Vuorio E, Aro H T. A standardized experimental fracture in the mouse tibia. J Orthop Res 1993; 11 (2): 305-12.
13. Kang S C, Matsutani T, Choudhry M A, Schwacha M G, Rue L W, Bland K I, et al. Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage? Cytokine 2004; 26 (5): 223-30.
14. Kon T, Cho T J, Aizawa T, Yamazaki M, Nooh N, Graves D, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001; 16 (6): 1004-14.
15. Lewis D B, Liggitt H D, Effmann E L, Motley S T, Teitelbaum S L, Jepsen K J, et al. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci U S A 1993; 90 (24): 11618-22.
16. Linkhart T A, Mohan S, Baylink D J. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone (1 Suppl) 1996; 19: 1S-12S.
17. Mack V E, McCarter M D, Naama H A, Calvano S E ,Daly J M. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131 (12): 1303-8; discussion 1308-9.
18. McKenzie G J, Fallon P G, Emson C L, Grencis R K, McKenzie A N. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189 (10): 1565-72.
19. Meert K L, Ofenstein J P ,Sarnaik A P. Altered T cell cytokine production following mechanical trauma. Ann Clin Lab Sci 1998; 28 (5): 283-8.
20. Nilsson O S, Bauer H C, Brosjo O, Tornkvist H. Influence of indomethacin on induced heterotopic bone formation in rats. Importance of length of treatment and of age. Clin Orthop 1986; (207): 239-45.
21. Olmedo M L, Landry P S, Sadasivan K K, Albright J A, Meek W D, Routh R, et al. Regulation of osteoblast levels during bone healing. J Orthop Trauma 1999; 13 (5): 356-62.
22. Reddi A H. Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop 1998; (355 Suppl): S66-72.
23. Schmidmaier G, Wildemann B, Heeger J, Gabelein T, Flyvbjerg A, Bail H J, et al. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1. Bone 2002; 31 (1): 165-72.
24. Shore E M, Glaser D L, Gannon F H. Osteogenic induction in hereditary disorders of heterotopic ossification. Clin Orthop 2000; (374): 303-16.
25. Silfversward C J, Frost A, Brandstrom H, Nilsson O, Ljunggren O. Interleukin-4 and interleukin-13 potentiate interleukin-1 induced secretion of interleukin-6 in human osteoblast-like cells. J Orthop Res 2004; 22 (5): 1058-62.
26. Silfversward C J, Larsson S, Ohlsson C, Frost A, Nilsson O. Reduced cortical bone mass in mice with inactivation of interleukin-4 and interleukin-13. J Orthop Res 2007; 25 (6): 725-31.
27. Sisask G, Bjurholm A, Ahmed M, Kreicbergs A. The development of autonomic innervation in bone and joints of the rat. J Auton Nerve Syst 1996; 59 (1-2): 27-33.
28. Skoglund B, Forslund C ,Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res 2002; 17 (11): 2004-8.
29. Street J, Winter D, Wang J H, Wakai A, McGuinness A, Redmond H P. Is human fracture hematoma inherently angiogenic? Clin Orthop 2000; (378): 224-37.
30. Szczesny G. Molecular aspects of bone healing and remodeling. Pol J Pathol 2002; 53 (3): 145-53.
31. Urist M R, DeLange R J, Finerman G A. Bone cell differentiation and growth factors. Science 1983; 220 (4598): 680-6.
32. Wildemann B, Schmidmaier G, Ordel S, Stange R, Haas N P, Raschke M. Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers, PCNA and BrdU. J Biomed Mater Res B Appl Biomater 2003; 65 (1): 150-6.
33. Windahl S H, Vidal O, Andersson G, Gustafsson J A, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999; 104 (7): 895-901.
34. Wozney J M, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998; (346): 26-37.
35. Zellweger R, Ayala A, DeMaso C M, Chaudry I H. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 1995; 4 (2): 149-53.